AlphaGen
Access AlphaGen
Company Narratives

Fateh Sports Wear Q3 FY26: Operations Stay Frozen While FX Swings Drive the Loss

Fateh Sports Wear remained revenue-free in Q3 FY26, while a foreign-exchange loss deepened losses and its restart still hinges on cash recovery and working capital.

Sep 21, 2026

Verdict

Fateh Sports Wear Limited's March 2026 quarter was not an operating turnaround. The company recorded no sales for either Q3 FY26 or the first nine months, and management explicitly attributed the absence of revenue to non-availability of orders. With no cost of sales and no gross profit, the result was driven almost entirely by administrative overhead and foreign-exchange remeasurement rather than manufacturing economics.

The headline deterioration was sharp: Q3 loss after tax widened to Rs3.30 million from Rs0.83 million, while the nine-month loss widened to Rs12.25 million from Rs2.43 million. The central reason was a Rs9.10 million exchange loss during 9MFY26 compared with a Rs0.20 million exchange gain a year earlier. That Rs9.30 million swing explains almost all of the roughly Rs9.82 million increase in the nine-month loss. The key question for the next cycle is therefore not margin recovery but whether the company can unlock its long-stuck foreign receivable, secure working capital and actually restart production.

Results at a glance

  • Company Name: Fateh Sports Wear Limited
  • Ticker: FSWL
  • Reporting period: Third quarter and nine months ended March 31, 2026.
  • Reporting basis: Company-level unaudited condensed interim financial statements prepared under IAS 34 and the Companies Act, 2017; the June 30, 2025 statement-of-financial-position comparative comes from the audited annual financial statements.
  • Q3 FY26: sales nil; operating loss Rs1.30m versus Rs0.93m; exchange loss Rs2.00m versus a Rs0.10m gain; PAT loss Rs3.30m versus Rs0.83m; loss per share Rs1.65 versus Rs0.41.
  • 9MFY26: sales nil; operating loss Rs3.06m versus Rs2.55m; exchange loss Rs9.10m versus a Rs0.20m gain; PAT loss Rs12.25m versus Rs2.43m; loss per share Rs6.12 versus Rs1.22.

The following four measures are AlphaGen model outputs, not company-reported figures.

  • Alpha QoQ Score: N/A
  • TTM Performance Score: N/A
  • 3Y Business Perf Score: N/A
  • Sector Leadership Score: 58.05

What improved

There was little operating improvement to point to because the business remained inactive. One positive is that the company still carries no bank borrowing in the interim balance sheet. Current liabilities were Rs38.77 million, dominated by Rs33.11 million of loans from directors, while bank loans and accrued bank markup were nil. That keeps conventional interest expense negligible: nine-month financial expense was only Rs121.

The company also retained positive book equity of Rs561.39 million at March 2026, down only 2.1% from June 2025 despite the nine-month loss. Current assets exceeded current liabilities by about Rs521.63 million, producing a headline current ratio of roughly 14.45x. On the surface, this looks exceptionally liquid; the composition of those assets, however, makes that ratio much less reassuring than it first appears.

What weakened / needs attention

The clearest weakness is the persistence of zero revenue. Q3 administrative expense rose about 40.0% year on year to Rs1.30 million, and nine-month administrative expense rose 20.3% to Rs3.06 million. In a functioning manufacturer, overhead can be absorbed by gross profit. Here, every rupee of recurring administration falls directly into operating loss because there is no production revenue.

The exchange line then magnified the loss. Q3 moved from a Rs0.10 million exchange gain last year to a Rs2.00 million loss, while the nine-month period moved from a Rs0.20 million gain to a Rs9.10 million loss. Q3 PAT therefore became about four times the comparable loss, and the nine-month loss became roughly five times larger. This is important because the deterioration did not come from falling gross margin or higher input costs: there were no sales or cost of sales to begin with.

Why the foreign receivable dominates the economics

At March 31, 2026, trade receivables stood at Rs558.10 million, down exactly Rs9.10 million from Rs567.20 million at June 2025. That reduction matches the nine-month exchange loss. The company's July 2026 progress report says management is still pursuing release of a stuck US$2.00 million amount and links any operating restart to release of those funds and availability of working capital. Taken together with the company's earlier disclosures about this foreign receivable, it is reasonable to infer that the March-period exchange loss largely reflects remeasurement of the receivable rather than an operating cash expense.

That distinction matters. A currency remeasurement can move reported profit substantially without changing the amount of cash actually collected. The economic issue is recovery. Until the legal restriction is resolved and the money is received, the receivable remains a balance-sheet asset rather than usable liquidity for production.

Balance sheet: headline liquidity is concentrated in one asset

The balance sheet looks unusually liquid if judged only by current assets versus current liabilities. But Rs558.10 million of the Rs560.40 million of current assets was trade receivables — about 99.6%. Cash and bank balances were only Rs118,155. The receivable also represented roughly 93.0% of total assets. This concentration means FSWL's reported current ratio is not comparable with the liquidity of an operating textile company holding cash, marketable inventory and a diversified customer receivable book.

Director funding remains the immediate cash bridge. Loans from directors increased to Rs33.11 million from Rs30.28 million at June 2025 and represented roughly 85% of current liabilities. The notes show Rs2.83 million of director loans were received during the nine months. That amount was almost exactly sufficient to cover the reported Rs2.80 million net cash outflow from operations.

Cash conversion therefore remained weak. Net operating cash outflow widened to Rs2.80 million from Rs0.57 million in the comparable period, while there was no investing cash flow. Closing cash rose by only Rs35,224 to Rs118,155 because new director funding offset the operating outflow. With no inventory, no capital spending in the cash-flow statement and no sales, there is not yet financial-statement evidence of a production restart.

What changed versus the historical pattern

The March result is best understood as continuation of a long-running dormant-business pattern rather than a new cyclical downturn. The company's December 2025 interim notes state that manufacturing restarted briefly in 2013 but was closed again in March 2015 because scarce financial resources made operations unviable. The notes identify blocked funds connected with Russia as the core reason for the company's financial distress.

Company-published six-year financial highlights show zero sales from 2019 through 2025, while reported profit and loss swung sharply from year to year. FY2023, for example, showed profit after tax of Rs158.2 million, FY2024 a loss of Rs19.9 million and FY2025 a profit of Rs7.0 million despite zero sales in each year. This history reinforces why FSWL's accounting profit cannot be read as evidence of operating momentum: foreign-exchange and other non-operating movements can dominate the income statement while the factory remains inactive.

Sector context: the industry had demand, but FSWL did not capture it

The wider textile and apparel environment was challenging but not devoid of demand. Pakistan's Economic Survey 2025-26 reports that textile exports were broadly stable at about US$13.5 billion during July-March FY26, while readymade-garment exports increased 3.8% to about US$3.2 billion. PBS separately reported that readymade-garment exports in March 2026 were down 6.48% year on year, illustrating a softer month inside a still-positive nine-month value-added export trend.

This does not mean FSWL should automatically have won orders; its scale, customer relationships, production readiness and financing constraints are company-specific. But it does mean zero sales cannot simply be explained by the absence of an export market. The company's own board review says it had no sales because orders were unavailable, and its later progress report says management has been contacting international buyers for export orders. That makes order conversion, alongside financing, a genuine company-specific execution test.

Recurring versus exceptional drivers

The recurring cost base is currently small but structurally negative: administrative expenses, depreciation, utilities and compliance costs continue while revenue is zero. Unless production restarts, this overhead should be viewed as the recurring core of the income statement rather than as a temporary one-off.

The foreign-exchange result is different. It can recur while the US-dollar receivable remains outstanding, but its direction and size depend on currency movements and accounting remeasurement. It is not operating earnings and it does not itself create cash. The Rs9.10 million exchange loss explains the vast majority of the year-on-year deterioration in 9MFY26, so treating the loss expansion as a collapse in manufacturing performance would be misleading; manufacturing was already inactive.

Director loans are also financing, not earnings. They have allowed the company to meet ongoing cash needs despite minimal cash on hand, but continued dependence on related-party funding is not the same as self-funded operations. A durable restart would require cash recovery, working capital, customer orders and evidence that production can generate gross profit.

Post-period developments and listing risk

The most important post-period update came in the company's July 6, 2026 quarterly progress report. Management said it remained in pursuit of the case for release of the US$2.00 million stuck amount, expected vacation of the stay order, and intended to resume operations once that happened. It also said it had developed an international marketing strategy and begun contacting buyers, while making production restart conditional on receipt of the funds and availability of working capital. These are management expectations and plans, not evidence that production has restarted.

There is also a separate market-access risk. The PSX company page currently labels FSWL 'NON-COMPLIANT' and carries a risk warning that continuous violation under the cited listing-regulation clauses may expose the company to trading suspension or delisting. The PSX page does not, in the warning itself, explain the underlying violation, so it would be inappropriate to speculate about the cause. The status is nevertheless material for shareholders and should be monitored alongside the operating restart.

What to monitor next

  • Recovery of the US$2.00 million stuck amount: this remains the single most consequential balance-sheet event. Cash receipt would convert the company's dominant current asset into usable liquidity.
  • Legal progress on the stay order: management has explicitly tied resumption of operations to vacation of the stay order. A concrete court or company update matters more than repeated expressions of confidence.
  • Working-capital funding: even after recovery of the receivable, management says production requires working capital. Watch for funding arrangements and whether director loans continue to rise.
  • Actual orders and sales: buyer contacts are not revenue. The first meaningful signal of operational recovery would be disclosed orders, production, inventory movement and sales in the financial statements.
  • Cash rather than accounting FX: exchange gains or losses can materially move PAT while the receivable remains outstanding. Focus on collection and operating cash generation rather than currency-driven earnings swings.
  • Recurring overhead: with sales at zero, any increase in administration directly widens operating loss. Cost discipline matters until production restarts.
  • PSX compliance status: watch for removal of the non-compliant designation or any exchange notice clarifying the relevant listing-regulation issue.

Overall, Fateh Sports Wear's Q3 FY26 result is primarily a balance-sheet and restart story, not an earnings-growth story. The company has almost no conventional debt and large positive book working capital, but that apparent liquidity is concentrated almost entirely in one foreign receivable that has remained unavailable for years. The March-quarter loss widened because of administration and, especially, exchange remeasurement; director funding continued to cover day-to-day cash needs. The next result cycle becomes economically meaningful only if management converts legal progress, cash recovery and buyer outreach into funded production and actual sales.

Sources

Explore more research

All articles